Publications:

Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.

Leukemia

Ganesan, S S; Alex, A A AA; Chendamarai, E E; Balasundaram, N N; Palani, H K HK; David, S S; Kulkarni, U U; Aiyaz, M M; Mugasimangalam, R R; Korula, A A; Abraham, A A; Srivastava, A A; Padua, R A RA; Chomienne, C C; George, B B; Balasubramanian, P P; Mathews, V V

Publication Date: 2016-11

Variant appearance in text: TIEG1: F410L

PubMed Link: 27560113

Variant Present in the following documents:

• leu2016227a.pdf

View BVdb publication page